Anastasia Sarycheva
About Anastasia Sarycheva
Anastasia Sarycheva is a Senior Medical Information Officer in the TFS Oncology Division, with extensive experience in medical information roles. She has worked in the pharmaceutical industry since 2010, including positions at Novartis and TFS Trial Form Support in Barcelona, Spain.
Work at TFS HealthScience
Anastasia Sarycheva has been employed at TFS Trial Form Support since 2015. She currently holds the position of Senior Medical Information Officer in the Oncology Division. In this role, she is responsible for providing medical information support and ensuring compliance with regulatory standards within oncology projects. Prior to her current position, she worked as a Medical Information Expert in the TFS Genmed Division from 2012 to 2015, where she contributed to the management of medical inquiries and supported various therapeutic areas.
Previous Experience in the Pharmaceutical Industry
Before joining TFS, Anastasia Sarycheva worked at Novartis. She served as a trainee in sales and marketing training from 2010 to 2011 in Barcelona, Spain. Following this role, she worked as a Medical Information Expert in the Novartis Genmed Division from 2011 to 2012. Her experience at Novartis provided her with a solid foundation in pharmaceutical marketing and medical information management.
Education and Expertise
Anastasia Sarycheva holds two master's degrees. She studied at the Universitat de Barcelona from 2009 to 2011, where she completed her master's degree. Prior to that, she attended the Peoples’ Friendship University of Russia from 2003 to 2009, earning another master's degree. Her educational background equips her with the knowledge and skills necessary for her roles in medical information and oncology.
Background
Anastasia Sarycheva has a professional background in medical information and pharmaceutical sales and marketing. She has worked in various capacities within the industry, primarily in Barcelona, Catalonia, Spain. Her career spans over a decade, during which she has developed expertise in medical communication and regulatory compliance in the oncology field.